Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Aspira Pathlab & Diagnostics: Board Meeting Intimation for Approval Of Un-Audited Financial Result (Standalone) For The First Quarter Ended On June 30 2026 And To Transact Other Businesses
News Announcement

Aspira Pathlab & Diagnostics: Board Meeting Intimation for Approval Of Un-Audited Financial Result (Standalone) For The First Quarter Ended On June 30 2026 And To Transact Other Businesses

06-Aug-2026 Follow Value Research Online on Google download pdfDownload PDF Aspira Pathlab

Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve 1.Unaudited Financial Result(Standalone) along with Limited Review Report for the First Quarter ended June 30 2026 To consider evaluate and if deem fit to approve the proposal for raising of funds by way of issuance via various mode and to transact Other Businesses.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan